452 related articles for article (PubMed ID: 27379889)
21. The more the micropapillary pattern in stage I lung adenocarcinoma, the worse the prognosis-a retrospective study on digitalized slides.
Zombori T; Nyári T; Tiszlavicz L; Pálföldi R; Csada E; Géczi T; Ottlakán A; Pécsy B; Cserni G; Furák J
Virchows Arch; 2018 Jun; 472(6):949-958. PubMed ID: 29611055
[TBL] [Abstract][Full Text] [Related]
22. Micropapillary and solid subtypes of invasive lung adenocarcinoma: clinical predictors of histopathology and outcome.
Cha MJ; Lee HY; Lee KS; Jeong JY; Han J; Shim YM; Hwang HS
J Thorac Cardiovasc Surg; 2014 Mar; 147(3):921-928.e2. PubMed ID: 24199757
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma.
Hung JJ; Jeng WJ; Chou TY; Hsu WH; Wu KJ; Huang BS; Wu YC
Ann Surg; 2013 Dec; 258(6):1079-86. PubMed ID: 23532112
[TBL] [Abstract][Full Text] [Related]
24. New IASLC/ATS/ERS classification and invasive tumor size are predictive of disease recurrence in stage I lung adenocarcinoma.
Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
J Thorac Oncol; 2013 May; 8(5):612-8. PubMed ID: 23584293
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of stage I lung adenocarcinoma: A retrospective study based on analysis of 110 Chinese patients.
Zhao X; Zhang Y; Qian K; Zhao L; Wang W; Teng LH
Thorac Cancer; 2017 Nov; 8(6):565-571. PubMed ID: 28834269
[TBL] [Abstract][Full Text] [Related]
26. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
[TBL] [Abstract][Full Text] [Related]
27. Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma†.
Ito M; Miyata Y; Yoshiya T; Tsutani Y; Mimura T; Murakami S; Ito H; Nakayama H; Okada M
Eur J Cardiothorac Surg; 2017 Feb; 51(2):218-222. PubMed ID: 28186287
[TBL] [Abstract][Full Text] [Related]
28. [Selection of postoperative adjuvant therapy for patients with stage IB lung adenocarcinoma: analysis of 653 cases].
Shen L; Chen Y; Yun T; Guo J; Liu X; Zhang T; Liang C; Liu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2024 May; 44(5):989-997. PubMed ID: 38862458
[TBL] [Abstract][Full Text] [Related]
29. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.
Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Fujimoto M; Kawakami F; Tsuruyama T; Travis WD; Date H; Haga H
J Thorac Oncol; 2013 Jan; 8(1):52-61. PubMed ID: 23242438
[TBL] [Abstract][Full Text] [Related]
30. Modified histologic classification as a prognostic factor in pulmonary adenocarcinoma.
Hwang I; Park KU; Kwon KY
Int J Surg Pathol; 2014 May; 22(3):212-20. PubMed ID: 24599899
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of grading systems in stage I lung adenocarcinomas: a retrospective cohort study.
Zombori T; Furák J; Nyári T; Cserni G; Tiszlavicz L
J Clin Pathol; 2018 Feb; 71(2):135-140. PubMed ID: 28747392
[TBL] [Abstract][Full Text] [Related]
32. Application of Lepidic Component Predominance to Adjuvant Chemotherapy with Oral Fluoropyrimidines for Stage I Lung Adenocarcinoma.
Sasada S; Miyata Y; Mimae T; Tsutani Y; Mimura T; Okada M
Clin Lung Cancer; 2016 Sep; 17(5):433-440.e1. PubMed ID: 26725850
[TBL] [Abstract][Full Text] [Related]
33. Value of adjuvant chemotherapy in patients with resected stage IB solid predominant and solid non-predominant lung adenocarcinoma.
Cao S; Teng J; Xu J; Han B; Zhong H
Thorac Cancer; 2019 Feb; 10(2):249-255. PubMed ID: 30561142
[TBL] [Abstract][Full Text] [Related]
34. Identification of a low risk subgroup of stage IB lung adenocarcinoma patients.
Mizuno T; Ishii G; Nagai K; Yoshida J; Nishimura M; Mochizuki T; Kawai O; Hasebe T; Ochiai A
Lung Cancer; 2008 Dec; 62(3):302-8. PubMed ID: 18486987
[TBL] [Abstract][Full Text] [Related]
35. Why do pathological stage IA lung adenocarcinomas vary from prognosis?: a clinicopathologic study of 176 patients with pathological stage IA lung adenocarcinoma based on the IASLC/ATS/ERS classification.
Zhang J; Wu J; Tan Q; Zhu L; Gao W
J Thorac Oncol; 2013 Sep; 8(9):1196-202. PubMed ID: 23945388
[TBL] [Abstract][Full Text] [Related]
36. Minor histological components predict the recurrence of patients with resected stage I acinar- or papillary-predominant lung adenocarcinoma.
Liu W; Zhang Q; Zhang T; Li L; Xu C
Front Oncol; 2022; 12():1090544. PubMed ID: 36620572
[TBL] [Abstract][Full Text] [Related]
37. Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non-small cell lung cancer.
Zhang P; Duan J; Bai H; Wang Z; Gao S; Tan F; Gao Y; Wang X; Wan R; Xu J; He X; Feng X; Yu R; Sun J; Zhao Z; Fei K; Li N; He J; Wang J
Thorac Cancer; 2021 Jan; 12(1):30-39. PubMed ID: 33111432
[TBL] [Abstract][Full Text] [Related]
38. Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC.
Shen ZQ; Feng KP; Fang ZY; Xia T; Pan S; Ding C; Xu C; Ju S; Chen J; Li C; Zhao J
J Cardiothorac Surg; 2024 Jan; 19(1):1. PubMed ID: 38166960
[TBL] [Abstract][Full Text] [Related]
39. The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.
Eguchi T; Kadota K; Park BJ; Travis WD; Jones DR; Adusumilli PS
Semin Thorac Cardiovasc Surg; 2014; 26(3):210-22. PubMed ID: 25527015
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance and survival benefits of postoperative adjuvant chemotherapy in patients with stage IA lung adenocarcinoma with non-predominant micropapillary components.
Li R; Qiu J; Li Z; Li H; Tang Z; Yu W; Tian H; Sun Z
World J Surg Oncol; 2024 Jan; 22(1):32. PubMed ID: 38273367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]